JP Stock MarketDetailed Quotes

Shin Nippon Biomedical Laboratories (2395)

Watchlist
  • 1220
  • +37+3.13%
20min DelayMarket Closed May 15 15:30 JST
50.79BMarket Cap11.12P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shin Nippon Biomedical Laboratories (2395) Revenue Breakdown Overview

By Business/Source

Currency:JPY
2025/FY
Stock NameRevenueRatio
Contract research organization (CRO) business31.6B97.47%
Others1.79B5.52%
Medipolis business564.93M1.74%
Translational research business54.16M0.17%
US real estate business45.98M0.14%
Adjustment amount-1.64B-5.05%
View all

By Country/Region

Currency:JPY
2025/FY
Stock NameRevenueRatio
Japan21.52B66.40%
United States of America6.37B19.66%
South Korea4.02B12.40%
Others498.21M1.54%
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -